Related references
Note: Only part of the references are listed.The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
Frank Schwoebel et al.
BLOOD (2013)
A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes
Axel Vater et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy
Gabriela Schneider et al.
MOLECULAR CANCER RESEARCH (2013)
A Novel C5a-neutralizing Mirror-image (L-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis
Kai Hoehlig et al.
MOLECULAR THERAPY (2013)
Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
Jason G. Cyster et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
In vitro selection of Escherichia coli O157:H7-specific RNA aptamer
Young Ju Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis
Suriyan Ponnusamy et al.
EMBO MOLECULAR MEDICINE (2012)
Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease
Murthy N. Darisipudi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration
Roger A. Sabbadini
BRITISH JOURNAL OF PHARMACOLOGY (2011)
A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors
Mark A. Dickson et al.
CLINICAL CANCER RESEARCH (2011)
Development of a Sphingosylphosphorylcholine Detection System Using RNA Aptamers
Katsunori Horii et al.
MOLECULES (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
A novel lipopolysaccharide-antagonizing aptamer protects mice against endotoxemia
Ai-qing Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Sphingosine 1-phosphate induces vesicular endothelial growth factor expression in endothelial cells
Kyun Heo et al.
BMB REPORTS (2009)
Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-β-stimulated collagen production by cardiac fibroblasts
Nicole Gellings Lowe et al.
CARDIOVASCULAR RESEARCH (2009)
Single-Stranded DNA Oligoaptamers: Molecular Recognition and LPS Antagonism Are Length- and Secondary Structure-Dependent
J. L. Ding et al.
JOURNAL OF INNATE IMMUNITY (2009)
Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies
Nicole O'Brien et al.
JOURNAL OF LIPID RESEARCH (2009)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide
Thomas Denekas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo
WG Purschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
B Visentin et al.
CANCER CELL (2006)
Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases
J Chun et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The mechanism of membrane targeting of human sphingosine kinase 1
RV Stahelin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role for sphingosine kinases in neural and vascular development
K Mizugishi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Aptamers that recognize the lipid moiety of the antibiotic moenomycin A
H Betat et al.
BIOLOGICAL CHEMISTRY (2003)
VEGF induces S1P1 receptors in endothelial cells:: Implications for cross-talk between sphingolipid and growth factor receptors
J Igarashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mfold web server for nucleic acid folding and hybridization prediction
M Zuker
NUCLEIC ACIDS RESEARCH (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization
EJ Su et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation.
KN Meadows et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
YJ Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Functions of a new family of sphingosine-1-phosphate receptors
S Spiegel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Insulin-like growth factor I stimulates angiogenesis and the production of vascular endothelial growth factor
SE Dunn
GROWTH HORMONE & IGF RESEARCH (2000)
Share Paper
